Propanc Biopharma issues $60,000 promissory note to accredited investor

Propanc Biopharma, Inc.

Principal amount $60,000; purchase price $50,000 (implicit $10,000 discount).
Maturity July 15, 2025; interest at 10% per annum.
Repayment at 100% of principal if on/before July 7, 2025; 120% if after through Aug 7, 2025.
Proceeds for general working capital; note issued under Section 4(a)(2) private placement.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.